0000899243-20-019087.txt : 20200714 0000899243-20-019087.hdr.sgml : 20200714 20200714170036 ACCESSION NUMBER: 0000899243-20-019087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200622 FILED AS OF DATE: 20200714 DATE AS OF CHANGE: 20200714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naschitz Anat CENTRAL INDEX KEY: 0001792060 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 201027591 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-22 0 0001785173 89bio, Inc. ETNB 0001792060 Naschitz Anat C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 1 0 1 0 Stock Option (Right to Buy) 24.29 2020-06-22 4 A 0 7000 0.00 A 2030-06-22 Common Stock 7000 7000 I See footnote This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, which will vest in full on June 22, 2021, subject to the Reporting Person's continued service to the Issuer through such date. These securities are held of record by Anat Naschitz ("Naschitz"), an employee of OrbiMed Advisors Israel II Limited ("Israel II Limited"). Pursuant to an agreement between Israel II Limited, OrbiMed Israel GP II, L.P. ("Israel II GP"), OrbiMed Advisors LLC ("OrbiMed Advisors"), and OrbiMed Capital GP VI LLC ("GP VI"), Naschitz is obligated to transfer these securities, or the economic benefit thereof, to Israel II Limited, Israel II GP, OrbiMed Advisors, and GP VI, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP and OrbiMed Israel Partners II, L.P. /s/ Ryan A. Murr, as attorney-in-fact for Anat Naschitz 2020-07-14